Urvi Shah Selected Research

Urvi Shah Research Topics

12	Multiple Myeloma 05/2024 - 01/2020
5	Neoplasms (Cancer) 03/2023 - 01/2020
2	Residual Neoplasm 06/2021 - 05/2021
1	Neutropenia 02/2024
1	Agammaglobulinemia (Hypogammaglobulinemia) 02/2024
1	Infections 02/2024
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 06/2023
1	Smoldering Multiple Myeloma 11/2022
1	Exanthema (Rash) 01/2022
1	Hemorrhage 01/2022
1	Venous Thromboembolism 01/2022
1	Alopecia (Baldness) 07/2020
1	Hypertension (High Blood Pressure) 06/2020
1	COVID-19 06/2020
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2019
1	Leukemia 01/2019
1	Adenoma (Adenomas) 01/2017

6	Dexamethasone (Maxidex)FDA LinkGeneric 02/2023 - 01/2020
6	Lenalidomide (CC 5013)FDA Link 02/2023 - 01/2021
4	carfilzomibIBA 02/2023 - 01/2021
3	Bortezomib (Velcade)FDA Link 02/2023 - 01/2022
2	ixazomibIBA 11/2022 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 05/2021 - 01/2020
1	Aligeron (AS 2)IBA 05/2024
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 02/2024
1	insulin receptor-related receptor (IRR)IBA 02/2024
1	B-Cell Maturation AntigenIBA 02/2024
1	RivaroxabanIBA 01/2022
1	dupilumabIBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	AnticoagulantsIBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Monoclonal AntibodiesIBA 05/2021
1	daratumumabIBA 05/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2020
1	Melphalan (Alkeran)FDA LinkGeneric 06/2020
1	Immunoglobulin G (IgG)IBA 06/2020
1	selinexorIBA 01/2020
1	Cytotoxins (Cytolysins)IBA 01/2020
1	dimemorfan (AT 17)IBA 01/2017

7	Therapeutics 02/2024 - 06/2020
1	Stem Cell Transplantation 06/2023
1	Artificial Respiration (Mechanical Ventilation) 06/2020
1	Lasers (Laser) 01/2020
1	Hematopoietic Stem Cell Transplantation 01/2019